Justera Health Ltd.
SCRSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $2 | $15 | $21 |
| % Growth | -25.8% | -87% | -31.3% | – |
| Cost of Goods Sold | $1 | $1 | $12 | $22 |
| Gross Profit | $1 | $1 | $3 | -$0 |
| % Margin | 62.9% | 44.8% | 17.6% | -1.5% |
| R&D Expenses | $0 | $0 | $0 | $1 |
| G&A Expenses | $3 | $4 | $5 | $3 |
| SG&A Expenses | $3 | $4 | $5 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $1 | -$2 |
| Operating Expenses | $3 | $5 | $6 | $4 |
| Operating Income | -$2 | -$4 | -$4 | -$3 |
| % Margin | -172.2% | -200% | -26.7% | -15% |
| Other Income/Exp. Net | -$1 | $1 | -$1 | -$6 |
| Pre-Tax Income | -$4 | -$3 | -$5 | -$9 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | -$4 | -$3 | -$5 | -$9 |
| % Margin | -296.6% | -155.7% | -35.7% | -43.8% |
| EPS | -0.024 | -0.023 | -0.06 | -0.24 |
| % Growth | -1.3% | 61.5% | 74.9% | – |
| EPS Diluted | -0.024 | -0.023 | -0.06 | -0.24 |
| Weighted Avg Shares Out | 179 | 128 | 87 | 42 |
| Weighted Avg Shares Out Dil | 179 | 128 | 87 | 42 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $1 | $0 |
| EBITDA | -$2 | -$3 | -$3 | -$3 |
| % Margin | -162.6% | -179.5% | -19.1% | -15.2% |